Discover the detailed record of transactions filed by 李力, Dirigeant. Officer active across 2 companies, notably 神州泰岳. Cumulatively, 65 reports have been recorded. Regulator: AMF. All data is accessible without signup.
Declarations 65 total
100,000 shares
SSE:273000000264513020 · 19 Mar 2026
Executives ● Sale神 神州泰岳 10 SZSE 4,590,000 shares
SZSE:173000008409332830 · 7 Jan 2025
Executives ● Purchase爱 爱尔眼科 11 SZSE 5,000 shares
SZSE:173000005689829440 · 15 Jul 2022
Ideal exit: 11 Apr 2023 (T+270) Executives ● Purchase爱 爱尔眼科 11 SZSE 5,000 shares
SZSE:173000005681551840 · 14 Jul 2022
Ideal exit: 10 Apr 2023 (T+270) Executives ● Purchase爱 爱尔眼科 14 SZSE 150,000 shares
SZSE:173000005649177630 · 1 Jul 2022
Ideal exit: 28 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 14 SZSE 54,700 shares
SZSE:173000005641036200 · 30 Jun 2022
Ideal exit: 27 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 18 SZSE 114,400 shares
SZSE:173000005614950050 · 23 Jun 2022
Ideal exit: 20 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 18 SZSE 200,000 shares
SZSE:173000005610978700 · 21 Jun 2022
Ideal exit: 18 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 18 SZSE 150,000 shares
SZSE:173000005605692350 · 17 Jun 2022
Ideal exit: 14 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 18 SZSE 99,500 shares
SZSE:173000005599321340 · 16 Jun 2022
Ideal exit: 13 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 15,000 shares
SZSE:173000005595967330 · 15 Jun 2022
Ideal exit: 12 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 10,000 shares
SZSE:173000005585460670 · 10 Jun 2022
Ideal exit: 7 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 5,000 shares
SZSE:173000005581163970 · 9 Jun 2022
Ideal exit: 6 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 2,000 shares
SZSE:173000005578660200 · 8 Jun 2022
Ideal exit: 5 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 5,000 shares
SZSE:173000005564436580 · 1 Jun 2022
Ideal exit: 26 Feb 2023 (T+270) Executives ● Purchase爱 爱尔眼科 18 SZSE 100,600 shares
SZSE:173000005564436540 · 1 Jun 2022
Ideal exit: 26 Feb 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 10,000 shares
SZSE:173000005560793300 · 31 May 2022
Ideal exit: 25 Feb 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 3,000 shares
SZSE:173000005555753570 · 27 May 2022
Ideal exit: 21 Feb 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 1,000 shares
SZSE:173000005552239070 · 26 May 2022
Ideal exit: 20 Feb 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 4,000 shares
SZSE:173000005547832130 · 24 May 2022
Ideal exit: 18 Feb 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 2,000 shares
SZSE:173000005545391140 · 23 May 2022
Ideal exit: 17 Feb 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 1,000 shares
SZSE:173000005542928000 · 20 May 2022
Ideal exit: 14 Feb 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 5,000 shares
SZSE:173000005522950560 · 12 May 2022
Ideal exit: 6 Feb 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 2,000 shares
SZSE:173000005503421700 · 29 Apr 2022
Ideal exit: 24 Jan 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 2,000 shares
SZSE:173000005491228640 · 28 Apr 2022
Ideal exit: 23 Jan 2023 (T+270) 25 of 65 declarations
Load more (40 remaining) About 李力 Li Li is a director at Shenzhou Taiyue and also an executive at Aier Eye Hospital, where he oversees operations and strategy for both companies. With significant experience in the sector, he is responsible for innovation and performance improvement. His leadership is a major asset for both organizations.